Gary Ingenito - May 13, 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
May 13, 2025
Transactions value $
-$4,887,560
Form type
4
Date filed
5/15/2025, 05:00 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
INGENITO GARY Chief Med. & Reg. Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Gary Ingenito 2025-05-15 0001279473

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $684K +200K +290.39% $3.42 269K May 13, 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$4.74M -200K -74.38% $23.68 68.9K May 13, 2025 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $204K +44K +63.89% $4.64 113K May 14, 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$1.04M -44K -38.98% $23.63 68.9K May 14, 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -200K -25.31% $0.00 590K May 13, 2025 Common Stock 200K $3.42 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -44K -7.45% $0.00 546K May 14, 2025 Common Stock 44K $4.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range between $23.325 and $23.93 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range between $23.44 and $24.025 per share.
F4 Options vested in three annual tranches beginning on December 30, 2021.
F5 Options vested in three annual tranches beginning on December 2, 2020.